Drug intelligence / Profile preview

boldenone undecylenate

Development stage
Unknown
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Boldenone undecylenate is a synthetic androgen and anabolic steroid (AAS) medication primarily used in veterinary medicine, especially for horses. It is an esterified form of boldenone, acting as a long-lasting prodrug that is administered by intramuscular injection. The drug exerts its effects by binding to the androgen receptor, leading to increased protein synthesis and muscle growth through gene transcription regulation. Boldenone undecylenate has strong anabolic effects with moderate androgenic activity and weak estrogenic properties. It was originally introduced for medical use in the 1960s but is now mainly used in animals to promote weight gain, improve appetite, and enhance physical condition following illness or overexertion. Human use has been discontinued due to side effects such as masculinization and its status as a controlled substance; it remains marketed for veterinary purposes in some countries[1][2][5][6].

Brand names
EquipoiseParenabol
Other names
boldenone undecenoateboldenone 10-undecenoateboldenone10-undecenoateboldenone-10-undecenoate17beta-Hydroxyandrosta-1,4-dien-3-one 10-undecenoate
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on boldenone undecylenate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on boldenone undecylenate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call